Protedyne Completes Installation of BioCube System at Correlagen
Complete the form below to unlock access to ALL audio articles.
Protedyne Corporation has announced it has completed the installation and site acceptance of its BioCube System LX 2000 at Correlagen Diagnostics.
Correlagen selected the BioCube System to automate their Genes That Matter™ gene testing service. The BioCube System will optimize their clinical workflow for throughput, analytical procedures, and data handling needs.
The BioCube System will integrate PCR setup, PCR cleanup, sequencing reaction setup, and sequencing reaction cleanup in a continuous process.
"We are pleased to have provided Correlagen with technology that addresses their need to automate complex testing protocols as well as the throughput requirements for their molecular diagnostic test menu," said Fran Tutttle, President and CEO of Protedyne. "We look forward to being a part of their future success."
"Protedyne’s BioCube System is proving to be an excellent platform for implementing Correlagen’s software and gene sequencing methods," said David Margulies, M.D., CEO of Correlagen.
"Our throughput, quality, and costs are unmatched, and the BioCube System is a major component of our success."
"Correlagen’s alliance program with academic and pharmaceutical collaborators is based in large part on the capabilities we have created on this automated platform," added Joyce Samet, Senior Vice President. "Correlagen looks forward to extending our relationship with Protedyne."
